Hiroaki Ogata

454 total citations
37 papers, 235 citations indexed

About

Hiroaki Ogata is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Oncology. According to data from OpenAlex, Hiroaki Ogata has authored 37 papers receiving a total of 235 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 8 papers in Physiology and 7 papers in Oncology. Recurrent topics in Hiroaki Ogata's work include Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Respiratory Support and Mechanisms (5 papers). Hiroaki Ogata is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Respiratory Support and Mechanisms (5 papers). Hiroaki Ogata collaborates with scholars based in Japan, Germany and Canada. Hiroaki Ogata's co-authors include Makoto Yoshida, Atsushi Moriwaki, Koichiro Matsumoto, Yoichi Nakanishi, Hiromasa Inoue, Toru Takeshita, Yoshihisa Yamashita, Kenji Takeuchi, Jun Hata and Toshiharu Ninomiya and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Dental Research.

In The Last Decade

Hiroaki Ogata

29 papers receiving 230 citations

Peers

Countries citing papers authored by Hiroaki Ogata

Since Specialization

Citations

This map shows the geographic impact of Hiroaki Ogata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Ogata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Ogata more than expected).

Fields of papers citing papers by Hiroaki Ogata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Ogata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Ogata. The network helps show where Hiroaki Ogata may publish in the future.

Co-authorship network of co-authors of Hiroaki Ogata

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Ogata. A scholar is included among the top collaborators of Hiroaki Ogata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Ogata. Hiroaki Ogata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Secular Trends in the Prevalence of Total and Latent Prostate Cancer over Half a Century According to Consecutive Autopsy Cases in a Japanese community: The Hisayama Study 2025 ·European Urology Open Science ·Junichi Taira, (unknown), (unknown), Masaki Shiota, Hiroaki Ogata, (unknown), Emi Oishi, Satoko Sakata, Yoshihiko Furuta, Mao Shibata, Tomoyuki Ohara, Yoshinao Oda, (unknown), Toshiharu Ninomiya	0
2	Tezepelumab achieves improvement of severe uncontrolled asthma and rhinosinusitis: Case series 2025 ·Journal of Allergy and Clinical Immunology Global ·(unknown), Hiroaki Ogata, (unknown), Koichi Takagi, (unknown), Yumiko Ishii, Kentaro Tanaka, Keiko Kan‐o, Hiromasa Inoue	1
3	Relapsing eosinophilic pneumonia in a patient with recurrent breast cancer receiving abemaciclib plus endocrine therapy 2024 ·SHILAP Revista de lepidopterología ·Hiroaki Ogata, (unknown), Toyoshi Yanagihara, (unknown), (unknown), (unknown), (unknown), (unknown), Atsushi Moriwaki, Eriko Tokunaga, Makoto Yoshida	1
4	Amikacin Liposome Inhalation Suspension in the Real-World Management of Refractory Mycobacterium avium Complex Pulmonary Disease 2024 ·Cureus ·Toyoshi Yanagihara, Hiroaki Ogata, Asami Mori, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Makoto Yoshida	0
5	Impact of increased plasma levels of calreticulin on prognosis of patients with advanced lung cancer undergoing combination treatment of chemotherapy and immune checkpoint inhibitors 2023 ·Lung Cancer ·(unknown), Hiroyuki Inoue, Yoshimasa Shiraishi, (unknown), (unknown), Hiroyuki Ando, (unknown), (unknown), Hiroaki Ogata, Koji Okamura, Shinichi Kimura, Tomohiro Ogawa, Keiichi Ota, Yasuto Yoneshima, Kentaro Tanaka, Naoki Hamada, Isamu Okamoto, Eiji Iwama	8
6	Tezepelumab treatment for allergic bronchopulmonary aspergillosis 2023 ·SHILAP Revista de lepidopterología ·Hiroaki Ogata, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Atsushi Moriwaki, Makoto Yoshida	16
7	A Teaching Case: Persistent COVID-19 Pneumonia Resembling Cryptogenic Organizing Pneumonia in a Patient With Remitted Lymphoma 2023 ·Cureus ·Toyoshi Yanagihara, (unknown), (unknown), (unknown), (unknown), (unknown), Hiroaki Ogata, (unknown), Makoto Yoshida	2
8	An Unusual Case of Bilateral Lower Extremity Edema in the Elderly: Immunoglobulin A (IgA) Vasculitis 2023 ·Cureus ·Toyoshi Yanagihara, Takuya Nakagawa, (unknown), (unknown), Hiroaki Ogata, (unknown), (unknown), Makoto Yoshida	0
9	The Prognostic Performance of Lung Diffusing Capacity in Preserved Ratio Impaired Spirometry: An Observational Cohort Study 2022 ·International Journal of COPD ·Hiroaki Ogata, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Atsushi Moriwaki, Makoto Yoshida	6
10	The association between transfer coefficient of the lung and the risk of exacerbation in asthma-COPD overlap: an observational cohort study 2022 ·BMC Pulmonary Medicine ·Hiroaki Ogata, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hiroshi Aso, Atsushi Moriwaki, Makoto Yoshida	0
11	Nintedanib treatment for pulmonary fibrosis after coronavirus disease 2019 2021 ·Respirology Case Reports ·Hiroaki Ogata, (unknown), (unknown), (unknown), (unknown), (unknown), Atsushi Moriwaki, Makoto Yoshida	24
12	Association of serum antibodies against the Mycobacterium avium complex and hemoptysis: a cross-sectional study 2021 ·BMC Infectious Diseases ·Hiroaki Ogata, Atsushi Moriwaki, (unknown), (unknown), (unknown), (unknown), Hiroshi Aso, (unknown), (unknown), (unknown), Makoto Yoshida	2
13	Impact of visceral fat on the prognosis of coronavirus disease 2019: an observational cohort study 2021 ·BMC Infectious Diseases ·Hiroaki Ogata, Masahiro Mori, (unknown), Hiroshi Matsuzaki, (unknown), (unknown), (unknown), (unknown), Atsushi Moriwaki, Makoto Yoshida	16
14	Airflow limitation and tongue microbiota in community-dwelling elderly individuals 2021 ·ERJ Open Research ·Toru Takeshita, Koichiro Matsumoto, Michiko Furuta, Satoru Fukuyama, Kenji Takeuchi, Hiroaki Ogata, Mikari Asakawa, Shinya Kageyama, Jun Hata, Toshiharu Ninomiya, Hiromasa Inoue, Yoshihisa Yamashita	1
15	Increased plasma levels of damage-associated molecular patterns during systemic anticancer therapy in patients with advanced lung cancer 2021 ·Translational Lung Cancer Research ·Hiroyuki Inoue, (unknown), Kentaro Tanaka, Eiji Iwama, Yoshimasa Shiraishi, (unknown), (unknown), Hiroyuki Ando, (unknown), (unknown), Hiroaki Ogata, (unknown), Koji Okamura, Shinichi Kimura, Tomohiro Ogawa, Keiichi Ota, Yasuto Yoneshima, Naoki Hamada, Yoichi Nakanishi, Isamu Okamoto	16
16	Mycobacterium avium pleuritis with multiple nodules in the pleura 2020 ·Respirology Case Reports ·Hiroaki Ogata, Eiji Harada, T. Takao, Kayo Ijichi, Naoki Hamada, Koichiro Matsumoto	2
17	Trends in the prevalence of airflow limitation in a general Japanese population: two serial cross-sectional surveys from the Hisayama Study 2019 ·BMJ Open ·Hiroaki Ogata, Yoichiro Hirakawa, Koichiro Matsumoto, Jun Hata, Daigo Yoshida, Satoru Fukuyama, Hiromasa Inoue, Takanari Kitazono, Toshiharu Ninomiya, Yoichi Nakanishi	7
18	Seasonal and meteorological impacts on primary spontaneous pneumothorax 2018 ·Journal of Thoracic Disease ·Hiroaki Ogata, Koichiro Matsumoto, (unknown), Nobutaka Nakashima, Fumihiro Shoji, Hiroshi Koto	6
19	Chronic myelomonocytic leukemia blast crisis in a patient with advanced non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors 2017 ·Respiratory Investigation ·Hiroaki Ogata, Isamu Okamoto, Goichi Yoshimoto, (unknown), Kayo Ijichi, Eiji Iwama, Taishi Harada, Koichi Akashi, Yoichi Nakanishi	2
20	Light-Induced Color Changes of Acetylated Veneers of Kiri (Paulownia tomentosa Steud.) 1997 ·(unknown), Hiroaki Ogata, (unknown), (unknown), (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact